There were 1,890 press releases posted in the last 24 hours and 439,454 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Gene Therapy for Wet AMD

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image